Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Lorenzo Sabatelli

ResearcherPublications, citations & collaboration network

Lorenzo Sabatelli is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 50 works, 809 citations, an h-index of 12 and an i10-index of 12.

50
Works
809
Citations
12
h-index
12
i10-index

How has Lorenzo Sabatelli's publication output changed over time?

ScholarIQpublication output · 2002–2025

Output grew0% over the shown period — from 1 works in 2002 to 1 in 2025.

1
1
1
1
1
1
1
2
1
200220032004200820092016201820232025

What are the most-cited papers on Lorenzo Sabatelli?

ScholarIQmost cited works
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
Laith J. Abu‐Raddad, Lorenzo Sabatelli, Jerusha T. Achterberg, Jonathan D. Sugimoto, Ira M. Longini, Christopher Dye, M. Elizabeth Halloran
Proceedings of the National Academy of Sciences. 2009357 CitationsOPEN ACCESS
Waiting time distributions in financial markets
Lorenzo Sabatelli, Shane R. Keating, Joe Dudley, Peter Richmond
S9051360. 2002199 Citations
Non-monotonic spontaneous magnetization in a Sznajd-like consensus model
Lorenzo Sabatelli, Peter Richmond
S24688465. 200334 CitationsOPEN ACCESS
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America
Noopur Raje, G. David Roodman, Wolfgang Willenbacher, Kazuyuki Shimizu, Ramón García‐Sánz, Evangelos Terpos, Lisa Kennedy, Lorenzo Sabatelli, Michele Intorcia, Guy Hechmati
Journal of Medical Economics. 201825 CitationsOPEN ACCESS

Related on ScholarIQ

Galderma (Switzerland)
Institution
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
Paper
Waiting time distributions in financial markets
Paper
Non-monotonic spontaneous magnetization in a Sznajd-like consensus model
Paper
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America
Paper
PHASE TRANSITIONS, MEMORY AND FRUSTRATION IN A SZNAJD-LIKE MODEL WITH SYNCHRONOUS UPDATING
Paper
470M+ articles · free account